The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and...

Area of Science:

• Neurodegenerative diseases
• Stem cell research
• Drug discovery

Background:

• Alzheimer's disease (AD) and Parkinson's disease (PD) are prevalent neurodegenerative diseases with no effective treatments.
• Current preclinical models, primarily rodents, fail to capture the full complexity of non-Mendelian AD and PD.
• Decades of clinical trials have yielded limited success in translating preclinical findings.

Purpose of the Study:

• To advocate for a paradigm shift in AD and PD research models.
• To promote the use of human-induced pluripotent stem cell (hiPSC)-derived systems for disease modeling.
• To encourage the development of human-based in vitro models for drug discovery and therapeutic target assessment.

Main Methods:

• Utilizing human-induced pluripotent stem cells (hiPSCs) for disease modeling.
• Developing human-based in vitro systems for AD and PD research.
• Evaluating the efficacy of hiPSC-derived models in preclinical drug discovery.

Main Results:

• hiPSC-derived systems offer a more biologically relevant model for AD and PD compared to traditional animal models.
• Human-based in vitro models can improve the preclinical evaluation of potential therapeutics.
• This approach addresses limitations in modeling non-Mendelian forms of neurodegenerative diseases.

Conclusions:

• A shift towards hiPSC-based modeling is crucial for advancing AD and PD research.
• Human-based in vitro models hold significant promise for accelerating drug discovery and development.
• Improved modeling strategies are essential to overcome the translational gap in neurodegenerative disease therapeutics.